2022 · Digital health · open access
Role of decentralized clinical trials in cancer drug development: Results from a survey of oncologists and patients
de Las Heras et al.
The finding, in our words
Surveyed oncologists and patients indicated that decentralized trials aim to reduce patient burden, increase enrollment and retention, and improve trial logistics via remote data collection, supporting a patient-centric shift in oncology drug development.
A paraphrase to the Library’s standard, never the abstract. The source is one link away and is always the authority.